Create Alert
Watchlist

Concord Drugs

₹75.81
+0.47 (0.62%) 1D
BSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this

Performance

Open
76.39
Prev. Close
75.34
Volume
1,149
Total traded value
0.01 Cr
Upper Circuit
79.10
Lower Circuit
71.58

Fundamentals

Market Cap₹75Cr
ROE1.67%
P/E Ratio(TTM)129.90
EPS(TTM)0.58
P/B Ratio2.19
Dividend Yield0.00%
Industry P/E33.35
Book Value34.42
Debt to Equity0.50
Face Value10
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Concord Drugs

Concord Drugs Limited is an Indian pharmaceutical company where the management is committed to achieving excellence through comprehensive quality management in all its operations. The company's strategic focus is on creating innovative drug delivery systems, including technologies like Sustained Release and Modified Release pellets, using the latest processes. It runs a state-of-the-art cGMP contract manufacturing facility, offering a full range of services for pharmaceutical development and drug product manufacturing. The company has also established robust internal financial controls to ensure the safety of its assets and the reliability of its financial transactions. Its main strength lies in delivering complete end-to-end solutions to customers and partners with its Ready-to-Fill Pellets and Finished Pharmaceutical Formulations. This positions Concord among a select few Indian pharmaceutical companies with a cutting-edge WHO-GMP certified facility, enabling the production of superior quality products.;
Parent OrganisationConcord Drugs Limited
Managing DirectorMr. S. Nagi Reddy
Founded1995
BSE Symbol538965

Shareholding Pattern

Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Promoters
54.39%
Retail And Others
45.61%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
JB Chemicals & Pharmaceuticals
NA
(0.00%)
38.48
Emcure Pharmaceuticals
NA
(0.00%)
32.22
Wockhardt
NA
(0.00%)
-450.68
Cohance Lifesciences
NA
(0.00%)
66.37